MAPK3 and sarcoma: Thus, the first cluster of 10 cancertypes includes the gastric, pancreatic, lung, kidney, bladder, thyroid,cervical, sarcoma, and glioblastoma cancers, where ERK1/2 pathway activation isa rather negative prognostic biomarker (for 90–100% of cluster 1 cancertypes).